Here are five things to know about the potential failure and potential re-appropriation of digital health startups.
1. In Accenture’s analysis of 900 health IT startups, 51 percent were determined to be in danger of failing within 20 months.
2. However, the startups that are in danger of failing collectively have $4 billion in investment funding.
3. Accenture deems these startups “zombie startups,” as they are faltering but bigger companies — vulture capitalists — could mine their talent and innovation, bringing pieces of them back to life.
4. Accenture offered three key benefits for larger companies acquiring elements of the zombie startups: a gathering of top talent, increased innovation and enhancing current solutions.
5. “In a period of disruption, leading organizations understand that they cannot keep doing the same things and expect to succeed,” said Kaveh Safavi, MD, managing director of Accenture’s global healthcare business. “They must become disruptors instead of being disrupted. Acquiring a failing health IT startup with excellent people and promising intellectual capital could be just the prescription for achieving that goal.”
More articles on digital health:
10 recent health IT tips from CIOs, vendors
Revolutionizing personal health through wearables & mHealth innovations
Considering a digital health program? 5 steps to follow
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
